The CEO of VIVEbiotech, Dr. Gurutz Linazasoro, appointed Chair of Asebio

The CEO of VIVEbiotech, Dr. Gurutz Linazasoro, was appointed Chair of the new Board of Directors of Asebio, the Spanish Association of Bioenterprises. at the meeting held on December 18.

In addition to the renewal of 5 Chairs, during this meeting the new presidency was appointed along with three vice presidencies. Ana Polanco, Director of Market Access and Corporate Affairs of Merck Spain, was elected President by Asebio's partners. Together with Polanco, Vice Presidents Belén Barreiro, General Director of Ingenasa (First Vice Presidency), Elena Rivas, CEO of A4Cell (Second Vice Presidency) and Javier Terriente, CSO de Zeclinics (Third Vice Presidency) were appointed.

Congratulations to all of them, and thanks to Asebio for its work in promoting Spanish bio-companies.

Contact us

Mikeletegi Pasealekua 81, San Sebastián 20009, Gipuzkoa (SPAIN)